NASDAQ : CLYD
Celldex Therapeutics, Inc. — Company profile
United States
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Clywedog Therapeutics, Inc., a small-molecule drug discovery company, develops therapies for the management and potential reversal of type 1 and type 2 diabetes. The company is based in Dover, Delaware.
Details
| Name | Clywedog Therapeutics, Inc. |
| Ceo | Iain Dukes |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
Key executives
| Name | Title |
|---|---|
| Iain Dukes | Chief Executive Officer |
| Nikolay Savchuk | Chief Operating Officer |
Contact
| Address | 8 The Green, Suite 8666, Dover, Delaware 19901, United States |
| Website | https://www.clywedogther.com |